HSBC Holdings’s Evogene EVGN Stock Holding History

HSBC Holdings’s Portfolio EVGN Stock Details EVGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-10,000	Closed	-$318K	–	2598
2018 Q1	$318K	Hold	10,000	–	–	﹤0.01%	2164
2017 Q4	$307K	Hold	10,000	–	–	﹤0.01%	1704
2017 Q3	$444K	Hold	10,000	–	–	﹤0.01%	1766
2017 Q2	$506K	Hold	10,000	–	–	﹤0.01%	1694
2017 Q1	$535K	Hold	10,000	–	–	﹤0.01%	1587
2016 Q4	$510K	Buy	+10,000	New	+$572K	﹤0.01%	1825
2015 Q4	–	Sell	-1,500	Closed	-$124K	–	2230
2015 Q3	$124K	Buy	+1,500	New	+$131K	﹤0.01%	1855
2014 Q1	–	Sell	-7,500	Closed	-$1.47M	–	1753
2013 Q4	$1.47M	Buy	+7,500	New	+$1.39M	﹤0.01%	1185

Other funds holding EVGN

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

MCM

Moon Capital Management New York $166M AUM 54.85% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HSBC Holdings's EVGN Position: Q2 2018 in Review

HSBC Holdings sold out of Evogene (EVGN) in Q2 2018, closing a stake of 10,000 shares — an estimated $318K sold.

HSBC Holdings first reported a position in EVGN in Q4 2013 and held it in 8 quarters. The position peaked at $1.47M in Q4 2013. 24 funds tracked by Wall St. Rank hold EVGN as of Q2 2018.

HSBC Holdings reported no remaining Evogene position as of Q2 2018 after selling out during the quarter.
HSBC Holdings sold 10,000 Evogene shares in Q2 2018, an estimated $318K.
HSBC Holdings first reported a position in Evogene in Q4 2013 and held it in 8 quarters.
HSBC Holdings's Evogene position peaked at $1.47M in Q4 2013.
24 funds tracked by Wall St. Rank held Evogene as of Q2 2018.

Based on HSBC Holdings's 13F filing for Q2 2018, filed 10 Aug 2018.